Literature DB >> 14657546

Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women? Data from the Women's Pooling Project.

Jennifer E Ho1, Furcy Paultre, Lori Mosca.   

Abstract

BACKGROUND AND
PURPOSE: Diabetes mellitus is an independent risk factor for stroke and is associated with a 1.8- to approximately 6-fold increased risk compared with nondiabetic subjects. Recent guidelines have classified diabetes as a coronary heart disease risk equivalent. Whether diabetes is a cardiovascular disease risk equivalent for stroke is not established.
METHODS: Data were pooled from 9 prospective epidemiological studies in the United States. We followed up 27,269 women (8.5% diabetic, 2.9% with prior myocardial infarction, 2.3% with prior stroke) for an average of 8.3 years, during which 238 stroke deaths were observed.
RESULTS: Both diabetic subjects without cardiovascular disease and nondiabetic subjects with history of prior stroke had a significantly increased risk of 10-year stroke mortality compared with nondiabetic subjects without prior cardiovascular disease (hazard ratio [HR], 6.77; 95% confidence interval [CI], 4.56 to 10.05; HR, 3.37; 95% CI, 2.38 to 4.77). History of prior myocardial infarction was not associated with long-term stroke mortality (HR, 0.66; 95% CI, 0.27 to 1.61). After adjustment for risk factors, diabetic subjects had similar risk compared with subjects with a history of prior stroke (HR, 1.29; P=0.43).
CONCLUSIONS: Diabetic subjects without cardiovascular disease have a fatal stroke risk similar to that of nondiabetic subjects with a history of prior stroke and similar risk factor profile. This suggests that diabetes mellitus may be classified as a stroke risk equivalent and may warrant more aggressive treatment strategies in the future prevention of stroke.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14657546     DOI: 10.1161/01.STR.0000102901.41780.5C

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  21 in total

Review 1.  Statins and the prevention of stroke in diabetes.

Authors:  Mary Ann Banerji
Journal:  Curr Diab Rep       Date:  2005-02       Impact factor: 4.810

Review 2.  Atorvastatin: a review of its use in the primary prevention of cardiovascular events in patients with type 2 diabetes mellitus.

Authors:  Katherine F Croom; Greg L Plosker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  The effect of diabetes and stroke at baseline and during follow-up on stroke mortality.

Authors:  G Hu; P Jousilahti; C Sarti; R Antikainen; J Tuomilehto
Journal:  Diabetologia       Date:  2006-08-01       Impact factor: 10.122

4.  Type 2 diabetes among rural Hispanics in Washington State: perspectives from community stakeholders.

Authors:  Jennifer C Livaudais; Beti Thompson; Ilda Islas; Genoveva Ibarra; Ruby Godina; Gloria D Coronado
Journal:  Health Promot Pract       Date:  2010-05-20

Review 5.  Impact of Conventional Stroke Risk Factors on Stroke in Women: An Update.

Authors:  Tracy E Madsen; Virginia J Howard; Monik Jiménez; Kathryn M Rexrode; Maria Czarina Acelajado; Dawn Kleindorfer; Seemant Chaturvedi
Journal:  Stroke       Date:  2018-02-08       Impact factor: 7.914

Review 6.  Cardiovascular disease in diabetes and the cardiometabolic syndrome: focus on minority women.

Authors:  John Nicasio; Fadi El-Atat; Samy I McFarlane; Judith H LaRosa
Journal:  Curr Diab Rep       Date:  2005-06       Impact factor: 4.810

Review 7.  Update on type 2 diabetes as a cardiovascular disease risk equivalent.

Authors:  Johanna Kuusisto; Markku Laakso
Journal:  Curr Cardiol Rep       Date:  2013-02       Impact factor: 2.931

8.  Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound.

Authors:  Yu Kataoka; Mingyuan Shao; Kathy Wolski; Kiyoko Uno; Rishi Puri; E Murat Tuzcu; Stanley L Hazen; Steven E Nissen; Stephen J Nicholls
Journal:  Atherosclerosis       Date:  2013-12-19       Impact factor: 5.162

Review 9.  Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives.

Authors:  Dirk Sander; Mark T Kearney
Journal:  J Neurol       Date:  2009-04-29       Impact factor: 4.849

Review 10.  Should all diabetic patients be treated with a statin?

Authors:  Yehuda Kamari; Rafael Bitzur; Hofit Cohen; Aviv Shaish; Dror Harats
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.